Terms: = Pancreatic cancer AND STAT5B, STAT5, 6777, ENSG00000173757, P51692 AND Prognosis
5 results:
1. Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma.
Fu D; Yan J; Zhang Z; Liu Y; Ma X; Ding J; Yang S; Zhao R; Chang A; Gao C; Liu J; Zhao T; Wang X; Huang C; Gao S; Ma Y; Tang B; Feng Y; Wang H; Hao J
Cancer Biol Med; 2023 Jun; 20(8):599-626. PubMed ID: 37381714
[TBL] [Abstract] [Full Text] [Related]
2. A novel immune checkpoint score system for prognostic evaluation in pancreatic adenocarcinoma.
Chen Y; Lin X; Zou X; Qian Y; Liu Y; Wang R; Wang X; Yu X; Liu C; Cheng H
BMC Gastroenterol; 2023 Apr; 23(1):113. PubMed ID: 37024802
[TBL] [Abstract] [Full Text] [Related]
3. pancreatic cancer is associated with aberrant monocyte function and successive differentiation into macrophages with inferior anti-tumour characteristics.
Juusola M; Kuuliala K; Kuuliala A; Mustonen H; Vähä-Koskela M; Puolakkainen P; Seppänen H
Pancreatology; 2021 Mar; 21(2):397-405. PubMed ID: 33461933
[TBL] [Abstract] [Full Text] [Related]
4. Fibroblasts as a Biological Marker for Curative Resection in pancreatic Ductal Adenocarcinoma.
Katsuta E; Rashid OM; Takabe K
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32485981
[TBL] [Abstract] [Full Text] [Related]
5. stat5b as molecular target in pancreatic cancer--inhibition of tumor growth, angiogenesis, and metastases.
Moser C; Ruemmele P; Gehmert S; Schenk H; Kreutz MP; Mycielska ME; Hackl C; Kroemer A; Schnitzbauer AA; Stoeltzing O; Schlitt HJ; Geissler EK; Lang SA
Neoplasia; 2012 Oct; 14(10):915-25. PubMed ID: 23097626
[TBL] [Abstract] [Full Text] [Related]
